Page last updated: 2024-08-25

chitosan and Arteriosclerosis Obliterans

chitosan has been researched along with Arteriosclerosis Obliterans in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eckl, S; Ensminger, SM; Goldmann, K; Hoffmann, J; Spriewald, BM	1

Other Studies

1 other study(ies) available for chitosan and Arteriosclerosis Obliterans

Article	Year
Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles. Transplant immunology, 2013, Volume: 28, Issue:1 Topics: Administration, Oral; Animals; Arteriosclerosis Obliterans; Benzofurans; Chitosan; Chronic Disease; DNA; Graft Rejection; Heart Transplantation; Isoantigens; Major Histocompatibility Complex; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Nanoparticles; Postoperative Complications; Quinolines; Transplantation Tolerance; Treatment Outcome	2013

Article

Year

Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles.

Transplant immunology, 2013, Volume: 28, Issue:1

Topics: Administration, Oral; Animals; Arteriosclerosis Obliterans; Benzofurans; Chitosan; Chronic Disease; DNA; Graft Rejection; Heart Transplantation; Isoantigens; Major Histocompatibility Complex; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Nanoparticles; Postoperative Complications; Quinolines; Transplantation Tolerance; Treatment Outcome

2013